Skip to main content

Pfizer JKI 5 (Xeljanz 5 mg)

Generic Name: tofacitinib

Pill with imprint Pfizer JKI 5 is White, Round and has been identified as Xeljanz 5 mg. It is supplied by Pfizer, Inc.

Xeljanz is used in the treatment of ulcerative colitis; ankylosing spondylitis; rheumatoid arthritis; psoriatic arthritis; juvenile idiopathic arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer JKI 5

Xeljanz

Generic Name
tofacitinib
Imprint
Pfizer JKI 5
Strength
5 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Antirheumatics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer, Inc.
National Drug Code (NDC)
00069-1001
Inactive Ingredients
microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, magnesium stearate, titanium dioxide, triacetin, polyethylene glycol 3350, hypromellose 2910 (6 mPa.s)

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.